AzTrials
AzTrials

Anesthesia, GeneralPrecision GANCT00829803

A Study to Assess Indices of SNAP vs VISTA on Surgical Patients Undergoing General Anesthesia

A study testing SNAP monitor; Bispectral Index Monitor (BIS Monitor) in people with Anesthesia, General, run by Stryker Instruments at 4 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Establish the range of index values for the SNAP II corresponding to each anesthetic state studied. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Anesthesia, General
What is being tested?
SNAP monitor; Bispectral Index Monitor (BIS Monitor)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
4 sitesUnited States
Study dates
Feb 2009to Jan 2011
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patients scheduled for surgery requiring general anesthesia
  • Open or laparoscopic procedures
  • Cases anticipated to be less than 4 hours in duration
  • In-patient and out-patient subjects
  • Patients and cases manageable with LMA. Cases manageable with ET tube are also allowed with the condition that only a minimal dose of short-acting NMBA is used at intubation and not throughout the case.
  • Local analgesia at incision site is permitted.
Show all 11Show fewer
  • Males and Females between 18 and 65 years of age, inclusive.
  • BMI<40 and body mass>41 kg
  • Patients who have signed the informed consent.
  • Able to receive Informed Consent through subjects native language providing that a native language speaker delivers the Informed Consent.
  • ASA Stratification I - III

Who cannot join

  • Any subject failing to fulfill all inclusion criteria
  • ASA stratification >= IV
  • Subject is a prisoner.
  • Patients presenting with evidence of recent trauma, active infection, neurological disorder, seizure disorder, dementia or have been diagnosed with Alzheimer's disease
  • Subjects with cardiac or gastric pace makers
  • Pregnant women as identified by institutional SOP for female of child-bearing age
Show all 25Show fewer
  • Patients that will not sign an informed consent form
  • Patients with previous adverse incidents with anesthesia, including awareness
  • Patients undergoing surgery on the head or neck
  • Subjects currently taking psychoactive medications as part of routine medical care within the past 7 days
  • Subjects that require and/or receive any of the psychotherapeutic agents or psychotropic drugs below, in the treatment of mental illness, and have taken such treatment within the past 7 days.
  • Benzodiazepines
  • MAOI inhibitors
  • Selective serotonin reuptake inhibitors (SSRIs)
  • Tricyclic antidepressants
  • Lithium
  • Neuroleptic agents
  • Central nervous system stimulants.
  • Subjects with a known history of alcohol or narcotic abuse within 6 months prior to screening OR subjects reporting narcotic or narcotic medication use with 24 hours prior to surgery.
  • Subjects requiring neurophysiologic monitoring
  • Subjects requiring TIVA
  • Subjects requiring prolonged use of NMBA beyond dose required for intubation
  • Subjects requiring ketamine
  • Subjects receiving spinal, epidural, or other nerve blocks
  • Subjects having any condition or severe illness that to the Principal Investigator's discretion would interfere with study assessments OR other severe acute or chronic medical or psychiatric condition that may interfere with the interpretation of study results and, in the judgment of the investigator, and would make the subject inappropriate for entry into this study.

Trial locations and contacts

4 sites in 1 country.

United States4 sites
  • Northwestern University Feinberg School of Medicine

    Chicago, Illinois, 60611

  • The Ohio State University Medical Center

    Columbus, Ohio, 43210

  • University Of Miami

    Miami, Florida, 33101-6370

  • Beaumont Hospital

    Royal Oak, Michigan, 48084

Other trials in United States

About this study

Official title: A Prospective Randomized Double Blinded Study Assessing Indices of SNAP vs VISTA on Surgical Patients Undergoing General Anesthesia

Establish the range of index values for the SNAP II corresponding to each anesthetic state studied.

Read the detailed description

Index values for the SNAP II monitor will be identified with each corresponding anesthetic state studied.

Being tested
SNAP monitor; Bispectral Index Monitor (BIS Monitor)
Keywords
To acquire developmental data to prospectively support SNAP, II index ranges at the studied anesthetic states.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SNAP monitor; Bispectral Index Monitor (BIS Monitor)Device

    Also called SNAP II monitor, BIS Monitor

    Intended to monitor the state of the brain by data acquisition of EEG signals.

Study groups in NCT00829803
Study groupRoleWhat they receive
SNAP Monitor EEG signalsExperimentalNot described
Receives: Device: SNAP monitor; Bispectral Index Monitor (BIS Monitor)
BIS Monitor EEG signals (VISTA)Active comparatorNot described
Receives: Device: SNAP monitor; Bispectral Index Monitor (BIS Monitor)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. SNAP Index values corresponding to anesthetic states: Pre-induction (baseline), loss of response, anesthesia maintenance, first purposeful response after anesthesia is discontinued, at extubation or LMA removal

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jan 2009 (estimated)
  2. Study startFeb 2009
  3. Primary completionJan 2011
  4. Study completionJan 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00829803
Sponsor's protocol ID
SIS-SNAP-2008-01US
Acronym
Precision GA
Status last verified
Jun 2011
First submitted
23 Jan 2009
Last updated
9 Nov 2021
Results posted
No
Data monitoring committee
No

Publications

  • Bergese SD, Uribe AA, Puente EG, Marcus RL, Krohn RJ, Docsa S, Soto RG, Candiotti KA. A Prospective, Multicenter, Single-Blind Study Assessing Indices of SNAP II Versus BIS VISTA on Surgical Patients Undergoing General Anesthesia. JMIR Res Protoc. 2017 Feb 3;6(2):e15. doi: 10.2196/resprot.6741.

    PubMed 28159731

Questions about this trial

What is this clinical trial studying?

A study testing SNAP monitor; Bispectral Index Monitor (BIS Monitor) in people with Anesthesia, General, run by Stryker Instruments at 4 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 25 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

SNAP Index values corresponding to anesthetic states: Pre-induction (baseline), loss of response, anesthesia maintenance, first purposeful response after anesthesia is discontinued, at extubation or LMA removal (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00829803, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Nov 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in